$CTKB News

Stephens & Co. Maintains Overweight on Cytek Biosciences, Lowers Price Target to $4.75

Morgan Stanley Maintains Equal-Weight on Cytek Biosciences, Lowers Price Target to $5.5

Cytek Biosciences, Inc. 2026 Q1 - Results - Earnings Call Presentation

Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript

Cytek Biosciences Affirms FY2026 Sales Guidance of $205.000M-$212.000M vs $208.235M Est

Cytek Biosciences Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $44.135M Miss $44.328M Estimate

Cytek Biosciences, Inc. (CTKB) Presents at TD Cowen 46th Annual Health Care Conference - Slideshow

Cytek (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. Q4 2025 Earnings Call Summary

Cytek Biosciences, Inc. 2025 Q4 - Results - Earnings Call Presentation

Cytek Biosciences Inc (CTKB) Q4 2025 Earnings Call Highlights: Record Revenue Amidst Challenges

Cytek Biosciences Q4 Earnings Call Highlights

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences Inc (NASDAQ:CTKB) Reports Q4 2025 Revenue Beat and Mixed Earnings

Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results  and Provides 2026 Outlook

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences Sees FY2026 Sales $205.000M-$212.000M vs $207.058M Est

Earnings Breakdown: Cytek Biosciences Q4

Cytek Biosciences Q4 EPS $(0.34) Misses $(0.02) Estimate, Sales $62.141M Beat $57.187M Estimate

Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference